Events

August 05, 2021
Second Quarter 2021 Financial Results and Business Highlights Conference Call at 8:30 am ET
Dial-In: 800-908-1236 (Domestic) / 212-231-2938 (international)
Webcast
June 01, 2021
Jefferies Healthcare Conference at 3:00 p.m. ET.
Webcast
May 26, 2021
UBS Global Healthcare Virtual Conference at 10:00 am ET
Webcast
May 21, 2021
Oppenheimer's Rare & Orphan Disease Summit at 9:55 am ET
Webcast
May 18, 2021
First Quarter 2021 Financial Results and Business Highlights Conference Call at 8:30 am ET
Dial-In: (877)-407-0989 (Domestic) / (201)-389-0921 (international)
Webcast
Presentation
April 06, 2021
Fiscal Year 2020 Financial Results and Business Highlights Conference Call
Webcast
March 17, 2021
Oppenheimer's 31st Annual Healthcare Conference at 10:40 am ET
Webcast
March 09, 2021
H.C. Wainwright Global Life Sciences Conference at 7:00 am ET
Webcast
January 11, 2021
H.C. Wainwright Virtual BioConnect Conference at 6:00 am ET
Webcast
January 11, 2021
Stern Investor Relations Corporate Access Event at 7:00am ET
Webcast
January 06, 2021
Stealth BioTherapeutics Granted Type B Pre-NDA Meeting for Elamipretide as a Treatment for Barth Syndrome at 8:30 a.m. ET
Dial in: US toll free: 877-407-0989
International: +1-201-389-0921
Webcast
May 21, 2019
UBS Global Healthcare Conference: 2:30 PM EDT
June 05, 2019
Jefferies 2019 Healthcare Conference at 3:00 PM ET
June 25, 2019
The BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference at 3:20 pm EDT
July 11, 2019
Stealth Biotherapeutics, Inc.'s KOL Breakfast
September 09, 2019
H.C. Wainwright Global Investment Conference
September 23, 2019
Ladenburg Thalmann Healthcare Conference
October 01, 2019
Cantor Global HC Conference
October 10, 2019
Stealth Announces Co-Development Partnership with Alexion for Mitochondrial Disease
November 14, 2019
Stealth BioTherapeutics Third Quarter 2019 Results
November 20, 2019
Jefferies London Healthcare Conference
December 20, 2019
Stealth BioTherapeutics Inc. Conference Call Webcast
February 18, 2020
Barth Syndrome Efficacy Study Using Natural History Data as a Control
8:30 AM ET
March 04, 2020
Stealth BioTherapeutics Presentation at 40th Annual Cowen Health Care Conference
at 10:40 am ET
April 01, 2020
Stealth BioTherapeutics Full Year 2019 Financial Results
at 8:30am ET
May 07, 2020
First Quarter 2020 Financial Results and Recent Business Highlights at 8:30am ET
May 19, 2020
Stealth BioTherapeutics Presentation: UBS Virtual Global Healthcare Conference at 12:30 PM EST
June 02, 2020
Stealth BioTherapeutics Presentation: Jefferies 2020 Healthcare Conference at 4:30pm EST
June 23, 2020
Stealth BioTherapeutics Fireside Chat: BMO 2020 Prescriptions for Success Healthcare Virtual Conference at 3:00pm EST
August 06, 2020
Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results at 8:30am EST
September 14, 2020
Stealth BioTherapeutics Presentation: H.C. Wainwright 22nd Annual Global Investment Conference at 4:30 pm ET
September 15, 2020
Cantor Fitzgerald's Virtual Global Healthcare Conference 2020 8:40 am ET
September 23, 2020
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit at 1:40 pm ET
November 05, 2020
Stealth BioTherapeutics to Report Third Quarter 2020 Financial Results at 8:30am EST
Media Relations

Amelia Stetler, 617-762-2562
media@stealthbt.com

Investor Inquiries
Stern IR
Janhavi Mohite, 212-362-1200
IR@stealthbt.com